Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop
Fierce Pharma
MAY 25, 2023
Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop zbecker Thu, 05/25/2023 - 10:42
Fierce Pharma
MAY 25, 2023
Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop zbecker Thu, 05/25/2023 - 10:42
Let's personalize your content